Seminari di Ematologia Oncologica - Società Italiana di Ematologia

14 Seminari di Ematologia Oncologica
3. Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE,
McGlave P, et al. Hematology basic principles and practice.
5 ed. Philadelphia: Churchill Livingstone; 2009.
4. Küppers R, Klein U, Hansmann ML, Rajewsky K.
Cellular origin of Human B-Cell Lymphomas. N Eng J
Med. 1999; 341: 1520-1529.
5. Lister TA, Crowther D, Sutcliffe SB, Glastein E,
Canellos GP, Young RC, et al. Report of a committee
convened to discuss the evaluation and staging of
patients with Hodgkin’s disease: Cotswolds meeting.
J Clin Oncol. 1989; 7: 1630-1636.
6. Carbone PP, Kaplan HS, Musshoff K, Smithers DW,
Tubiana M. Report of the Committee on Hodgkin’s
Disease Staging Classification. Cancer Res. 1971; 31:
1860-1861.
7. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS,
Rosenwald A, et al. Distinct types of diffuse large Bcell
lymphoma identified by gene espression profiling.
Nature. 2000; 403: 503-511.
8. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao
H, et al. Stromal gene signatures in large-B-cell lymphomas.
N Engl J Med. 2008; 359: 2313-2323.
9. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A,
Staudt LM. A gene expression-based method to diagnose
clinically distinct subgroups of diffuse large B cell
lymphoma. Proc Natl Acad Sci USA. 2003; 100: 9991-
9996.
10. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH,
Qian SB, Zhao H, et al. XBP1, downstream of Blimp-
1, expands the secretory apparatus and other
organelles, and increases protein synthesis in plasma
cell differentiation. Immunity. 2004; 21: 81-93.
11. Davis RE, Brown KD, Siebenlist U, Staudt LM.
Constitutive nuclear factor kappaB activity is
required for survival of activated B cell-like diffuse
large B cell lymphoma cells. J Exp Med. 2001; 194:
1861-1874.
12. Lam LT, Davis RE, Pierce J, Hepperle M, Xu Y, Hottelet
M, et al. Small molecule inhibitors of IkappaB kinase
are selectively toxic for subgroups of diffuse large Bcell
lymphoma defined by gene expression profiling.
Clin Cancer Res. 2005; 11: 28-40.
13. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt
LM. BCL-6 represses genes that function in lymphocyte
differentiation, inflammation, and cell cycle control.
Immunity. 2000; 13: 199-212.
14. Tam W, Gomez M, Chadburn A, Lee JW, Chan WC,
Knowles DM. Mutational analysis of PRDM1 indicates
a tumor-suppressor role in diffuse large B-cell lymphomas.
Blood. 2006; 107: 4090-4100.
15. Pasqualucci L, Compagno M, Houldsworth J, Monti
S, Grunn A, Nandula SV, et al. Inactivation of the
PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
J Exp Med. 2006; 203: 311-317.
16. Saito M, Gao J, Basso K, Kitagawa Y, Smith PM,
Bhagat G, et al. A signaling pathway mediating downregulation
of BCL6 in germinal center B cells is blocked
by BCL6 gene alterations in B cell lymphoma. Cancer
Cell. 2007; 12: 280-292.
17. Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J,
et al. Distinctive patterns of BCL6 molecular alterations
and their functional consequences in different subgroups
of diffuse large B-cell lymphoma. Leukemia.
2007; 21: 2332-2343.
18. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave
SS, Davis RE, et al. Molecular subtypes of diffuse large
B-cell Lymphoma arise by distinct genetic pathways.
Proc Natl Acad Sci USA. 2008; 105: 13520-13525.
19. Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P,
Mihm M, et al. Molecular profiling of diffuse large Bcell
lymphoma identifies robust subtypes including one
characterized by host inflammatory response. Blood.
2005; 105: 1851-1861.
20. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S,
Shinkai Y, Honjo T. Class switch recombination and
hypermutation require activation-induced cytidine
deaminase (AID), a potential RNA editing enzyme. Cell.
2000; 102: 553-563.
21. Pasqualucci L, Bhagat G, Jankovic M, Compagno M,
Smith P, Muramatsu M, et al. AID is required for germinal
center-derived lymphomagenesis. Nat Genet.
2008; 40: 108-112.
22. Pasqualucci L, Migliazza A, Fracchiolla N, William C,
Neri A, Baldini L, et al. BCL-6 mutations in normal germinal
center B cells: evidence of somatic hypermutation
acting outside Ig loci. Proc Natl Acad Sci USA.
1998; 95: 11816-11821.
23. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation
of BCL-6 gene in normal B cells by the process of
somatic hypermutation of Ig genes. Science. 1998; 280:
1750-1752.
24. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC,
Kleinstein SH, et al. Two levels of protection for the B
cell genome during somatic hypermutation. Nature.
2008; 451: 841-846.
25. Robbiani DF, Bunting S, Feldhahn N, Bothmer A,
Camps J, Deroubaix S, et al. AID produces DNA double-strand
breaks in non-Ig genes and mature B cell
lymphomas with reciprocal chromosome translocations.
Mol Cell. 2009; 36: 631-641.
26. Pasqualucci L, Neumeister P, Goossens T, Nanjangud
G, Chaganti RS, Küppers R, et al. Hypermutation of
multiple proto-oncogenes in B-cell diffuse large-cell
lymphomas. Nature. 2001; 412: 341-346.
27. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL,
Kuehl WM. Promiscuous translocations into
immunoglobulin heavy chain switch regions in multiple
myeloma. Proc Natl Acad Sci USA. 1996; 93:
13931-13936.
28. Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio
S, Chen-Kiang S, Muramatsu M, et al. AID is required
for c-myc/IgH chromosome translocations in vivo. Cell.
2004; 118: 431-438.
29. Ramiro AR, Jankovic M, Callen E, Difilippantonio S,